entertainment -WSS

entertainment

author：knowledge 2025-10-03 00:39:08 - browse：929

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： FDA drug safety: Singulair case shows systemic surveillance flaws

Wikipedia

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

What we need to know about Arena Bioworks

New oral drug delivery patch is modeled after octopus tentacles

European officials brace for rough respiratory virus season

Time to name cancers by genetics, not organ of origin, expert says

hotspot

entertainment

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Congressmen charge Covid hearing ‘could have been an email’

Affirmative action in medical school literally saved lives

Nobel honors Karikó and Weissman's enduring partnership

How to save PrEP access — and even expand it

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CRISPR base editing slashes cholesterol levels in monkeys

New air purifier tech could be key to improving indoor air quality

Even great ERs can’t make up for American health disparities

hotspot

Apple Vision Pro: A first look at health apps on the new VR headset

Juul spent big to court Black leaders to promote its e

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Setback for rare diseases as Taysha Gene Therapies pulls back

The biotech scorecard for Q4: 16 stock

SAMSHA loosens regulations on methadone treatment centers

explore

Wikipedia

Wikipedia

hotspot